polylactidecoglycolide

Polylactidecoglycolide, often abbreviated as PLGA, is a biocompatible and biodegradable copolymer widely used in medical devices and drug delivery systems. It is synthesized by the copolymerization of lactide and glycolide monomers. The ratio of these two monomers can be varied to control the degradation rate and mechanical properties of the resulting polymer. PLGA is known for its ability to break down into lactic acid and glycolic acid, which are naturally occurring metabolites in the body, making it safe for in vivo applications.

The degradation of PLGA is primarily through hydrolysis, where water molecules break the ester bonds within the polymer chain. This process leads to a gradual erosion of the material, releasing the encapsulated drugs or gradually resorbing the implant. Factors such as molecular weight, monomer ratio, crystallinity, and the surrounding physiological environment influence the degradation rate. Higher lactide content generally leads to slower degradation compared to higher glycolide content.

PLGA has found extensive applications in controlled drug release, where it can encapsulate a wide range of therapeutic agents, including proteins, peptides, and small molecules. It is used to create microspheres, nanoparticles, implants, and sutures that can deliver drugs over extended periods, reducing the frequency of administration and improving patient compliance. Its biocompatibility and predictable degradation profile make it a valuable material in regenerative medicine and tissue engineering as well.